Learn more about our Regulatory Affairs work.
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on President Trump’s nomination of Dr. Heidi Overton to serve as FDA commissioner.
Join MIDI as they provide a practical framework for developing SaMD products with regulatory requirements built into the development process.
Join Genpact as they provide a practical framework for connecting, governing, and activating service data – and a clear roadmap for scaling AI from pilot to confident business outcomes.
Chanhassen, MN — MedSource Labs today announced the launch of the ClearSafe Comfort® Closed System, the first slide-activated safety peripheral IV catheter (PIVC) with an integrated extension set to receive…
Join Suntra MedTech as they explore how AI is beginning to reshape the work of Quality and Regulatory—and what must not change.
Join Akin Gump as they provide actionable takeaways to minimize compliance risks and position organizations for effective and credible responses when FCA investigations arise.
WASHINGTON, D.C. – AdvaMed today announced that Juan Carlos “JC” Scott has been appointed Chief Strategy Officer and Executive Director of AdvaMed Accel, a newly created leadership position focused on…
AdvaMed’s recent submission to the Food and Drug Administration (FDA) provides comments on the Agency’s revised draft guidance governing communications between drug and device manufacturers and payors, formulary committees, and…
Experience the future of health care at the 2026 Medtech Showcase and Reception on Capitol Hill. Join AdvaMed® on September 16 for an interactive event featuring more than 25 medtech…
WASHINGTON, D.C.—AdvaMed, the Medtech Association, today expressed strong support for the draft Medical Device User Fee Amendments (MDUFA) VI agreement at an FDA public hearing.